Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1410100-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI M701TVIL1410100J1), received between Dec 31, 2016 and Mar 21, 2024 — classified as 5 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information2
- Lack of Effect2
- Adverse Event Without Identified Device or Use Problem1
- Complete Blockage1
- Device-Device Incompatibility1
- Patient-Device Incompatibility1
Patient problems
- Clinical Endoleak2
- Failure of Implant1
- Occlusion1
- Pain1
- Stenosis1
- Thrombosis1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryMar 21, 2024Lack of Effect; Lack of Effect
THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2020, WITH THE IMPLANT OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM. IT WAS REPORTED ON FEBRUARY 20, 2024, THAT DURING A ROUTINE FOLLOW-UP, A TYPE IB ENDOLEAK OF THE RIGHT COMMON ILIAC LIMB WAS IDENTIFIED. THE PATIENT'S STATUS IS CURRENTLY GOOD PENDING A RE-INTERVENTION.
Patient problems: Clinical Endoleak
MAUDE report 18955752 ↗InjuryMar 21, 2024Lack of Effect; Lack of Effect
THE PATIENT WAS TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2020, WITH THE IMPLANT OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM. IT WAS REPORTED ON FEBRUARY 20, 2024, THAT DURING A ROUTINE FOLLOW-UP, A TYPE IB ENDOLEAK OF THE RIGHT COMMON ILIAC LIMB WAS IDENTIFIED. THE PATIENT'S STATUS IS CURRENTLY GOOD PENDING A RE-INTERVENTION. ADDITIONAL INFORMATION: THE PATIENT UNDERWENT A RE-INTERVENTION PROCEDURE INVOLVING THE IMPLANTATION OF A GORE VBX STENT GRAFT (NON-ENDOLOGIX). THE PRECISE DATE OF THIS REINTERVENTION REMAINS UNKNOWN. THE FINAL PATIENT STATUS WAS REPORTED AS DOING WELL.
Patient problems: Clinical Endoleak
MAUDE report 18952428 ↗InjuryMay 22, 2021Complete Blockage; Device-Device Incompatibility; Insufficient Device Problem Information; Complete Blockage; Device-Device Incompatibility; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH THE OVATION ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). IT WAS REPORTED THAT WHILE THE PATIENT WAS IN RECOVERY THE PATIENTS LEFT LIMB AND EXTERNAL ILIAC IMMEDIATELY OCCLUDED AND THE PHYSICIAN HAD TO PERFORM A FEM FEM BYPASS. PATIENT WAS DISCHARGED ON AN UNKNOWN DATE. NOW, THE PATIENT HAS PRESENTED WITH SEVERE GROIN INFECTION FROM THE FEM FEM BYPASS AND POSSIBLE MULTIPLE TYPE II ENDOLEAKS. PATIENT IS IN CRITICAL CONDITION RECOVERING FROM THE INFECTION AND RE-INTERVENTION IS BEING DISCUSSED, BUT NOT YET SCHEDULED. ADDITIONAL INFORMATION RECEIVED PER CLINICAL ASSESSMENT INDICATING THAT NON-DEVICE-RELATED LEFT FOOT ISCHEMIA (DUE TO INFECTED FEMORAL-FEMORAL BYPASS GRAFT) AND A TYPE IA ENDOLEAK ALSO OCCURRED AT THE TIME OF THE REPORTED EVENT. NOTE: THE TYPE IA ENDOLEAK SELF-RESOLVED WITHIN 30 DAYS (NO TREATMENT WAS REQUIRED).
Patient problems: Failure of Implant
MAUDE report 11868134 ↗InjuryMar 17, 2020Patient-Device Incompatibility; Insufficient Device Problem Information; Patient-Device Incompatibility; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY ONE YEAR AND EIGHT MONTHS POST INITIAL PROCEDURE, THE PATIENT PRESENTED EMERGENTLY WITH LEG PAIN AND LIMB THROMBOSIS. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY PERFORMING BILATERAL ENDARTERECTOMIES, AND IMPLANTING BILATERAL SELF-EXPANDING STENTS IN THE COMMON AND EXTERNAL ILIACS. THE PHYSICIAN ALSO IMPLANTED A 10MM ATRIUM (NON-ENDOLOGIX) STENT IN THE SEALING RINGS IN RESPONSE TO AN ABNORMALLY SMALL AORTIC FLOW LUMEN (APPROXIMATELY 9MM). AS OF DATE, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Pain; Thrombosis
MAUDE report 9845388 ↗InjuryDec 31, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE 10 MONTH POST-OPERATIVE CT SHOWED THE PRESENCE OF AN OCCLUSION OF THE RIGHT ILIAC LIMB STENT GRAFT AND THROMBUS IN THE LEFT ILIAC LIMB STENT GRAFT IN THE PRESENCE OF ANATOMICAL NARROWING. THE PATIENT UNDERWENT A RE-INTERVENTION TO PLACE TWO BALLOON EXPANDABLE STENTS BILATERALLY TO MAINTAIN LUMENAL PATENCY. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Occlusion; Stenosis
MAUDE report 6216746 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page